131 related articles for article (PubMed ID: 1920354)
1. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
[TBL] [Abstract][Full Text] [Related]
2. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
Goghari MH; Franklin KJ; Moore GJ
J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
[TBL] [Abstract][Full Text] [Related]
4. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
Moore GJ; Ganter RC; Goghari MH; Franklin KJ
Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
6. The role of position 4 in angiotensin II antagonism: a structure-activity study.
Samanen J; Cash T; Narindray D; Brandeis E; Yellin T; Regoli D
J Med Chem; 1989 Jun; 32(6):1366-70. PubMed ID: 2724307
[TBL] [Abstract][Full Text] [Related]
7. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole.
Moore GJ; Ganter RC; Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P
J Mol Recognit; 1994 Dec; 7(4):251-6. PubMed ID: 7734150
[TBL] [Abstract][Full Text] [Related]
8. Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.
Samanen J; Narindray D; Cash T; Brandeis E; Adams W; Yellin T; Eggleston D; DeBrosse C; Regoli D
J Med Chem; 1989 Feb; 32(2):466-72. PubMed ID: 2913307
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
10. Differences in backbone structure between angiotensin II agonists and type I antagonists.
Matsoukas JM; Agelis G; Wahhab A; Hondrelis J; Panagiotopoulos D; Yamdagni R; Wu Q; Mavromoustakos T; Maia HL; Ganter R
J Med Chem; 1995 Nov; 38(23):4660-9. PubMed ID: 7473593
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
[TBL] [Abstract][Full Text] [Related]
13. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.
Hata T; Ogihara T; Nakamaru M; Gotoh S; Masuo K; Saeki S; Kumagai A; Kumahara Y
Eur J Clin Pharmacol; 1982; 23(1):7-10. PubMed ID: 6751836
[TBL] [Abstract][Full Text] [Related]
14. The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
Samanen J; Brandeis E; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Apr; 31(4):737-41. PubMed ID: 3351849
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation.
Noda K; Saad Y; Karnik SS
J Biol Chem; 1995 Dec; 270(48):28511-4. PubMed ID: 7499361
[TBL] [Abstract][Full Text] [Related]
16. Localization of central angiotensin II receptors with [125I]-sar1, ile8-angiotensin II: periventricular sites of the anterior third ventricle.
Healy DP; Maciejewski AR; Printz MP
Neuroendocrinology; 1986; 44(1):15-21. PubMed ID: 3785574
[TBL] [Abstract][Full Text] [Related]
17. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
Hsieh KH; LaHann TR; Speth RC
J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
[TBL] [Abstract][Full Text] [Related]
18. Actions of angiotensin II antagonists upon aldosterone production by isolated adrenal glomerulosa cells.
Saltman S; Fredlund P; Catt KJ
Endocrinology; 1976 Apr; 98(4):894-903. PubMed ID: 1278097
[TBL] [Abstract][Full Text] [Related]
19. The pressor response to exogenous angiotensin I and its blockade by angiotensin II analogues in the American alligator.
Silldorff EP; Stephens GA
Gen Comp Endocrinol; 1992 Jul; 87(1):141-8. PubMed ID: 1624094
[TBL] [Abstract][Full Text] [Related]
20. Conformational restriction of angiotensin II: cyclic analogues having high potency.
Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
